Admission Date:  [**2151-12-1**]       Discharge Date:  [**2151-12-5**]  Date of Birth:   [**2151-12-1**]       Sex:  M   HISTORY OF PRESENT ILLNESS:  [**Known lastname **] [**Known lastname 46336**], Triplet #3, was born at 32 weeks gestation by cesarean section for preterm labor and multiple gestation.
This pregnancy was conceived by intrauterine insemination.
Betamethasone course was completed on [**2151-11-10**].
He was extubated on day of life #1 to nasal cannula oxygen.
He is currently in nasal cannula oxygen, 200 cc liter of flow, 21 to 25% oxygen.
The infant was stated on Caffeine Citrate on day of life #1.
He has a normal cardiothymic silhouette on chest x-ray.
His total is 120 cc/kg/day of Premie Enfamil 20 or breast milk on a q.
Gastrointestinal status - Phototherapy was begun on day of life #3 for bilirubin of a total of 10.7 and direct 0.3.
Hematological status - The infant has received no blood products transfusion during his Neonatal Intensive Care Unit stay.
Infectious disease status - The infant was started on Ampicillin and Gentamicin at the time of admission for sepsis risk factors.
Antibiotics were discontinued after 48 hours when the blood cultures were negative and the infant was clinically well.
Caffeine Citrate 11 mg p.g.
Immunizations - The infant has not yet received any immunizations.
Recommend immunizations - I.  Synagis respiratory syncytial virus prophylaxis should be considered from [**Month (only) 359**] through [**Month (only) 547**] for infants who meet any of the following three criteria:  1.
Influenza immunization should be considered annually in the fall for preterm infants with chronic lung disease once they reach six months of age.
Before this age the family and other caregivers should be considered for immunization against influenza to protect the infant.
